Management of HCV‐infected health care workers
Nicola Magnavita, Ivo Iavicoli, Roberta Anna Placentino, Angelo Sacco, Vincenzo Puro – 30 December 2003
Nicola Magnavita, Ivo Iavicoli, Roberta Anna Placentino, Angelo Sacco, Vincenzo Puro – 30 December 2003
Hanako Yamamoto, Gary Quinn, Akira Asari, Hiroko Yamanokuchi, Takumi Teratani, Masaaki Terada, Takahiro Ochiya – 30 December 2003 – Embryonic stem (ES) cells provide a unique source for tissue regeneration. We examined whether mouse ES cells can efficiently differentiate into transplantable hepatocytes. ES cells were implanted into mouse livers 24 hours after carbon tetrachloride intoxication; ES‐derived cells with several hepatocyte‐cell‐markers were generated.
Michael Gale – 30 December 2003
Axel Ulsenheimer, J. Tilman Gerlach, Norbert H. Gruener, Maria‐Christina Jung, Carl‐Albrecht Schirren, Winfried Schraut, Reinhart Zachoval, Gerd R. Pape, Helmut M. Diepolder – 30 December 2003 – Chronic hepatitis C is characterized by a weak or absent hepatitis C virus (HCV)‐specific CD4+ T‐cell response in terms of antigen‐specific proliferation or interferon gamma (IFN‐γ) secretion.
Chung Mau Lo – 30 December 2003
Georgia Kostopanagiotou, Christina Routsi, Vassilios Smyrniotis, Marilena E. Lekka, Eirini Kitsiouli, Nikolaos Arkadopoulos, George Nakos – 30 December 2003 – The objective of this controlled experimental animal study was to evaluate whether acute hepatic failure (AHF) can cause acute lung injury (ALI) and to investigate possible pathophysiologic mechanisms. Seventeen domestic pigs were randomly assigned to AHF and sham groups. AHF was induced by surgical devascularization of liver in 10 animals. Seven animals were sham operated.
Nam‐On Ku, Roy M. Soetikno, M. Bishr Omary – 30 December 2003 – Hepatocytes express keratins 8 and 18 (K8/18) as their only cytoskeletal intermediate filament (IF) proteins, and K8/18 mutations predispose their carriers to liver cirrhosis. Transgenic mice that overexpress mutant human K18 (Arg89→Cys [R89C]) develop mild chronic hepatitis, hepatocyte fragility, keratin filament disruption, and increased susceptibility to drug‐induced liver injury.
Michele Barone, Eugenio Maiorano, Roberta Ladisa, Rosario Cuomo, Antonia Pece, Pasquale Berloco, Maria Lucia Caruso, Anna Maria Valentini, Achille Iolascon, Antonio Francavilla, Alfredo Di Leo, Enzo Ierardi – 30 December 2003 – Hepatitis B virus (HBV) transgenic mice (official designation, Tg [Alb‐1 HBV] Bri 44) invariably develop macroscopically evident tumors within the 20th month of life. Sustained proliferative activity seems to play an important role in the development of these lesions.
Javier Sola‐Vera, Josep Miñana, Elena Ricart, Montserrat Planella, Begoña González, Xavier Torras, Jose Rodríguez, José Such, Sonia Pascual, Germán Soriano, Miguel Pérez‐Mateo, Carlos Guarner – 30 December 2003 – Paracentesis‐induced circulatory dysfunction (PICD) is a recently described complication that can be prevented with the administration of plasma expanders. The aim of this study was to compare the efficacy of saline versus albumin in the prevention of PICD. Patients were randomized to receive albumin or saline after total paracentesis.
Claudio Puoti, Roberto Castellacci, Fabrizio Montagnese, Lia Bellis, Federica Festuccia, Paolo Corvisieri – 30 December 2003